| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |